Long term prospective observational cohort study of the safety and efficacy of certolizumab pegol in the daily clinical practice of rheumatoid arthritis with emphasis on the lipid profile.
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 29 May 2018
At a glance
- Drugs Certolizumab pegol (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 15 Jul 2011 New trial record